Quantitative Systematic Strategies’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-22,224
Closed -$502K 534
2021
Q1
$502K Buy
+22,224
New +$502K 0.08% 371
2020
Q3
Sell
-16,710
Closed -$397K 636
2020
Q2
$397K Buy
16,710
+4,257
+34% +$98.7K 0.08% 357
2020
Q1
$214K Buy
+12,453
New +$228K 0.18% 202
2016
Q3
Sell
-31,047
Closed -$242K 408
2016
Q2
$242K Buy
+31,047
New +$179K 0.11% 239
2016
Q1
Sell
-62,544
Closed -$354K 531
2015
Q4
$354K Buy
+62,544
New +$350K 0.1% 272

Other funds holding EXEL

Quantitative Systematic Strategies's EXEL Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Exelixis (EXEL) in Q2 2021, closing a stake of 22,224 shares — an estimated $502K sold.

Quantitative Systematic Strategies first reported a position in EXEL in Q4 2015 and held it in 5 quarters. The position peaked at $502K in Q1 2021. 344 funds tracked by Wall St. Rank hold EXEL as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining Exelixis position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 22,224 Exelixis shares in Q2 2021, an estimated $502K.
  • Quantitative Systematic Strategies first reported a position in Exelixis in Q4 2015 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Exelixis position peaked at $502K in Q1 2021.
  • 344 funds tracked by Wall St. Rank held Exelixis as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.